Embed this press release by copying the code below:

<a class="rwp-pr" href="http://rwire.com/580221">Pluristem Announces Significant New Finding from Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months</a><script>!function(){var e="rwp-platform";if(!document.getElementById(e)){var t=document.createElement("script");t.id=e,t.src=("https:"===document.location.protocol?"https":"http")+"://publisher.releasewire.com/embed.js",t.async=!0,document.body.appendChild(t)}}();</script>

Pluristem Announces Significant New Finding from Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months